• Publications
  • Influence
Serum levels of vitamin D are not associated with future risk of venous thromboembolism. The Tromsø Study.
Previous studies have provided indirect evidence for a possible association between vitamin D status and risk of venous thromboembolism (VTE). However, no study has so far investigated theExpand
  • 19
  • 1
  • PDF
Hyperglycemia, assessed according to HbA1c, and future risk of venous thromboembolism: the Tromsø study
HbA1c, a marker of average plasma glucose level during the previous 8–12 weeks, is associated with the future risk of cardiovascular disease and all‐cause mortality.
  • 16
Thyroid function, as assessed by TSH, and future risk of venous thromboembolism: the Tromsø study.
OBJECTIVE The relationship between thyroid function and the risk of venous thromboembolism (VTE) has not been addressed in population-based cohorts. We investigated the association between TSH levelsExpand
  • 5
  • PDF
Associations between serum levels of calcium, parathyroid hormone and future risk of venous thromboembolism: the Tromsø study.
OBJECTIVE The relationship between serum levels of calcium, parathyroid hormone (PTH) and risk of venous thromboembolism (VTE) has not been addressed in population-based cohorts. We investigated theExpand
  • 3
  • PDF
Endocrine-related factors and risk of venous thromboembolism
Jeg onsker ikke at det siste manuskriptet (paper 4) gjores tilgjengelig da denne studien ikke er publisert enna.